CRSP

CRISPR Therapeutics AG
Data: 2026-06-23
$53.99
Price
-0.68%
Change
$78.48
52W High
$43.23
52W Low

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Quick Stats
Jun 23, 2026

59.1

AI Score

HOLD

0.94

Volume Ratio

Aug 03, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

CRSP Stock Summary

Last updated Jun 23, 2026

CRSP is currently trading at $53.99, positioned below its 200-day moving average of $55.55, suggesting bearish momentum. The stock has a 52-week range of $43.2301 to $78.48.

Technical Analysis: The 50-day moving average stands at $52.85, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.504, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.005, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRSP at 59.1/100 with a HOLD recommendation.

CRSP (CRISPR Therapeutics AG) Indicators

Last updated Jun 23, 2026

Indicator Value
RSI(14) 54.504
CMF (20) -0.005
ROC (10) 4.632
ADX (14) 18.998
Indicator Value
MACD (12,26,9) 0.418
AROONOSC (14) -35.714
WILLAMS %R (14) -50.2
MFI (14) 50.387
CRSP Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CRSP Price vs Max Options Open Interest
CRSP Max Change In Options Open Interest

CRSP Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRSP Daily Out of Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRSP Daily In the Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRSP Most Active Options by Volume(near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

CRISPR Therapeutics AG is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CRSP Moving Averages Analysis

CRISPR Therapeutics AG has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026

CRSP (CRISPR Therapeutics AG) Simple Moving Averages

Moving Averages are last updated Jun 23, 2026

Days MA
10 52.11
20 52.87
30 52.03
50 52.85
100 52.14
200 55.55

CRSP Fundamental Analysis

P/E (Forward) 23.3645
P/E (Trailing) --
Market Cap ($) 5.5 billion
Earnings/Share ($) -6.17
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.8185
EPS Estimate Next Year ($) -3.8298
WallStreet Target Price ($) 83.5238
Most Recent Quarter